Adocia SA ADOC:Euronext Paris

RT Quote | Exchange | EUR
Last | 1:08 PM CEST
8.51quote price arrow up+0.10 (+1.19%)
Volume
27,869
52 week range
2.77 - 16.16
Loading...
  • Open8.43
  • Day High8.69
  • Day Low8.43
  • Prev Close8.41
  • 52 Week High16.16
  • 52 Week High Date08/29/23
  • 52 Week Low2.77
  • 52 Week Low Date05/03/23

Key Stats

  • Market Cap87.63M
  • Shares Out9.72M
  • 10 Day Average Volume59,057
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.26

KEY STATS

  • Open8.43
  • Day High8.69
  • Day Low8.43
  • Prev Close8.41
  • 52 Week High16.16
  • 52 Week High Date08/29/23
  • 52 Week Low2.77
  • 52 Week Low Date05/03/23
  • Market Cap87.63M
  • Shares Out9.72M
  • 10 Day Average Volume59,057
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-26.26

RATIOS/PROFITABILITY

  • EPS (TTM)-1.90
  • P/E (TTM)-4.48
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adocia SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Adocia SA is a clinical-stage biotechnology company based in France. The Company specializes in the development of formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary technological platform BioChaperone is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. The Company’s clinical pipeline includes four novel insulin...
Gerard Soula Ph.D.
Chairman of the Board
Olivier Soula Ph.D.
Chief Executive Officer,R&D Director, Vice President, Member of the Executive Committee, Director
Valerie Danaguezian
Chief Financial Officer, Administrative and Financial Director, Member of the Executive Committee
Address
115 avenue Lacassagne
Lyon
69003
France